Skip to main content
Caplight Logo









SquareMind

SquareMind

Private
ParisHealthcare & Life Scienceshttps://www.squaremind.com/

Last Round

Series A

Apr 27, 2026

Total Funding Raised

$20.63M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

SquareMind is a medical devices, health technology, and robotics company that has developed a robotic skin imaging platform for dermatology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Computer Vision

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

skin cancer detectiondermatology AImedical roboticsfull-body skin imagingmedical imaging AImole mappingAI-assisted diagnosticsautomated skin imagingmedical devicelesion mappinglesion trackingdigital dermatologydiagnostic AIclinical decision supportFDA listedCE mark

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SquareMind Comparables

Compare SquareMind with similar companies based on industry and business-model similarity.

SquareMind comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FotoFinder Systems GmbH
78%
Canfield Scientific
78%
DAMAE Medical
78%

SquareMind Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 27, 2026
GrantJun 7, 2022

Key People

Founding team and executive leadership

Tanguy Serrat

Co-Founder CTO

Founding Team

Ali Khachlouf

Co-Founder & CEO (HIRING )

Founding Team

SquareMind Investors

Notable investors and investment history

SquareMind investors
InvestorRounds
European Innovation Council FundGrant
Id4 VenturesEarly Funding, Accelerator
Adamed TechnologySeries A
EIT HealthGrant
Calm/Storm VenturesEarly Funding, Accelerator, Series A
Teampact VenturesSeries A
Entrepreneurs FirstEarly Funding, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    $18M round completed.

  • May 3, 2025

    Monthly visitors increased 649% MoM.

SquareMind Filings

Explore SEC and related filing metadata, where available.

SquareMind filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SquareMind's valuation, stock price, and market status.

Is SquareMind a public or private company?

SquareMind is a private company.

What is the current stock price of SquareMind?

SquareMind is a private company with no public stock price. No recent secondary market data is available.

How much is SquareMind worth (valuation)?

Valuation information for SquareMind is not publicly available.

Can I buy SquareMind stock?

SquareMind shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SquareMind's last funding round?

SquareMind's most recent funding round was Series A on April 27, 2026.

Who are the main investors in SquareMind?

Key investors in SquareMind include Sonder Capital.

Will SquareMind IPO soon?

No public IPO plans have been announced for SquareMind.

How can I track SquareMind secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SquareMind's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range18
Year Founded2019
Last FundingApr 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?